[
  {
    "rationale": "Names (losartan, atorvastatin), duration (~1 mo), adherence and absence of side-effects documented, but exact dosages (e.g., 50 mg, 10 mg) are completely missing.",
    "satisfaction": 70.0,
    "score": 17.5
  },
  {
    "rationale": "Notes typical control (\u201cmostly within target range\u201d) and one stress-related spike; gives instruction to report persistent elevations, but lacks specific numeric readings.",
    "satisfaction": 75.0,
    "score": 15.0
  },
  {
    "rationale": "Provides counseling to continue BP monitoring and secure adequate supply before travel; does not explicitly remind patient to take atorvastatin at night.",
    "satisfaction": 70.0,
    "score": 10.5
  },
  {
    "rationale": "No mention of renal/k\u207a labs after losartan start or lipid panel for statin; no stated reason for omission.",
    "satisfaction": 5.0,
    "score": 0.75
  },
  {
    "rationale": "Documentation is concise with no obvious copy-pasted past history or full med list.",
    "satisfaction": 95.0,
    "score": 9.5
  },
  {
    "rationale": "Gives contingency to report elevated BP but lacks concrete follow-up interval or plan if BP remains uncontrolled.",
    "satisfaction": 40.0,
    "score": 6.0
  }
]